Ginkgo biloba for memory problems after a mild stroke
Part of Brain & nervous system, Heart & circulation, Mental health clinical trials.
This trial tests whether adding ginkgo biloba extract tablets to standard stroke care helps improve memory and thinking in people who had a mild stroke. You may join if you are 55 or older, had a mild stroke in the last 1 to 2 weeks, and now have some cognitive difficulties.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 55 years or older.
- You had a mild stroke (not disabling) 7 to 14 days ago, confirmed with an MRI.
- You have some memory or thinking problems after the stroke.
- You can speak and understand Chinese for the study assessments.
- You did not have dementia or serious memory loss before the stroke.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking a ginkgo biloba extract supplement can help improve thinking and memory after a recent stroke. People who participate will receive the extract and have their cognitive function assessed with simple tests.
This trial tests whether a specific ginkgo biloba extract (EGb761) can improve thinking and memory in people with mild cognitive impairment (MCI). It also looks at changes in blood markers related to the condition.
This trial studies whether Ginkgo biloba, a natural supplement, can affect certain blood markers in people with mild cognitive impairment (MCI). It may help show how the supplement works in the body and whether it could be a helpful option for early memory problems.
This trial tests whether a combination of cilostazol (a blood flow medication) and ginkgo (a herbal supplement) can help protect memory and thinking skills in people over 60 with type 2 diabetes. You may join if your memory is slightly below normal but not severely impaired.
This study tests whether a concentrated form of ginkgo, given soon after an ischemic stroke (a stroke caused by a blocked blood vessel), can help improve recovery. It's only for people who start treatment within 48 hours of symptoms, so timing is critical.
This trial tests whether sodium oligomannate can help prevent or lessen memory and thinking problems that can happen after a first stroke. It may help people who are recently hospitalized for ischemic stroke and have mild cognitive decline risk.
Hear when a new Ischemic Stroke Hospitalized trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.